Category: Licensing/Collaboration Deal Region: Asia · Japan Company: Astellas Pharma Inc

Astellas And GO Therapeutics Enter Into Strategic Research And License Agreement To Develop Novel Antibodies For Immuno Oncology

By, Admin 1 min read
Share
Astellas And GO Therapeutics Enter Into Strategic Research And License Agreement To Develop Novel Antibodies For Immuno Oncology
Astellas Pharma Inc. and GO Therapeutics, Inc. announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas,

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!